Literature DB >> 20507312

All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma.

Amareshwar T K Singh1, Andrew M Evens, Reilly J Anderson, Jennifer A Beckstead, Natesan Sankar, Antonella Sassano, Savita Bhalla, Shuo Yang, Leonidas C Platanias, Trudy M Forte, Robert O Ryan, Leo I Gordon.   

Abstract

Mantle cell lymphoma (MCL) is characterized by translocation t(11;14)(q13;q32), aggressive clinical behaviour, and poor patient outcomes following conventional chemotherapy. New treatment approaches are needed that target novel biological pathways. All trans retinoic acid (ATRA) is a key retinoid that acts through nuclear receptors that function as ligand-inducible transcription factors. The present study evaluated cell killing effects of ATRA-enriched nanoscale delivery particles, termed nanodisks (ND), on MCL cell lines. Results show that ATRA-ND induced cell death more effectively than naked ATRA (dimethyl sulphoxide) or empty ND. ATRA-ND induced reactive oxygen species (ROS) generation to a greater extent than naked ATRA. The antioxidant, N-acetylcysteine, inhibited ATRA-ND induced apoptosis. Compared to naked ATRA, ATRA-ND enhanced G1 growth arrest, up-regulated p21and p27, and down regulated cyclin D1. At ATRA concentrations that induced apoptosis, expression levels of retinoic acid receptor-alpha (RARalpha) and retinoid X receptor-gamma (RXRgamma) were increased. Compared to naked ATRA, ATRA-ND significantly stimulated transcriptional activity of RARA in a model carcinoma cell line. Furthermore, the RAR antagonist, Ro 41-5253, inhibited ATRA-ND induced ROS generation and prevented ATRA-ND induced cell growth arrest and apoptosis. In summary, incorporation of ATRA into ND enhanced the biological activity of this retinoid in cell culture models of MCL.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20507312      PMCID: PMC2907750          DOI: 10.1111/j.1365-2141.2010.08209.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  46 in total

1.  Characterization of 4 mantle cell lymphoma cell lines.

Authors:  Hesham M Amin; Timothy J McDonnell; L Jeffrey Medeiros; Georgios Z Rassidakis; Vasiliki Leventaki; Sean L O'Connor; Michael J Keating; Raymond Lai
Journal:  Arch Pathol Lab Med       Date:  2003-04       Impact factor: 5.534

Review 2.  Mitochondria and apoptosis.

Authors:  D R Green; J C Reed
Journal:  Science       Date:  1998-08-28       Impact factor: 47.728

Review 3.  The promise of retinoids to fight against cancer.

Authors:  L Altucci; H Gronemeyer
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

4.  Retinoid receptor expression and its correlation to retinoid sensitivity in non-M3 acute myeloid leukemia blast cells.

Authors:  S Lehmann; C Paul; H Törmä
Journal:  Clin Cancer Res       Date:  2001-02       Impact factor: 12.531

5.  Expression of nuclear retinoic acid receptor in peripheral blood mononuclear cells (PBMC) of healthy subjects.

Authors:  L Szabova; D Macejova; M Dvorcakova; S Mostbock; S Blazickova; S Zorad; S Walrand; N Cardinault; M P Vasson; E Rock; J Brtko
Journal:  Life Sci       Date:  2003-01-03       Impact factor: 5.037

6.  Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.

Authors:  R Chiarle; L M Budel; J Skolnik; G Frizzera; M Chilosi; A Corato; G Pizzolo; J Magidson; A Montagnoli; M Pagano; B Maes; C De Wolf-Peeters; G Inghirami
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

7.  Autoinduction of retinoic acid metabolism to polar derivatives with decreased biological activity in retinoic acid-sensitive, but not in retinoic acid-resistant human breast cancer cells.

Authors:  B M van der Leede; C E van den Brink; W W Pijnappel; E Sonneveld; P T van der Saag; B van der Burg
Journal:  J Biol Chem       Date:  1997-07-18       Impact factor: 5.157

8.  Multiparameter immunohistochemical analysis of the cell cycle proteins cyclin D1, Ki-67, p21WAF1, p27KIP1, and p53 in mantle cell lymphoma.

Authors:  K F Izban; S Alkan; T P Singleton; E D Hsi
Journal:  Arch Pathol Lab Med       Date:  2000-10       Impact factor: 5.534

9.  Retinoids selective for retinoid X receptor response pathways.

Authors:  J M Lehmann; L Jong; A Fanjul; J F Cameron; X P Lu; P Haefner; M I Dawson; M Pfahl
Journal:  Science       Date:  1992-12-18       Impact factor: 47.728

Review 10.  Retinoic-acid-induced apoptosis in leukemia cells.

Authors:  A M Jiménez-Lara; N Clarke; L Altucci; H Gronemeyer
Journal:  Trends Mol Med       Date:  2004-10       Impact factor: 11.951

View more
  25 in total

Review 1.  High-Density Lipoproteins: Nature's Multifunctional Nanoparticles.

Authors:  Rui Kuai; Dan Li; Y Eugene Chen; James J Moon; Anna Schwendeman
Journal:  ACS Nano       Date:  2016-02-25       Impact factor: 15.881

2.  Anti-CD20 single chain variable antibody fragment-apolipoprotein A-I chimera containing nanodisks promote targeted bioactive agent delivery to CD20-positive lymphomas.

Authors:  Natasha M Crosby; Mistuni Ghosh; Betty Su; Jennifer A Beckstead; Ayako Kamei; Jens B Simonsen; Bing Luo; Leo I Gordon; Trudy M Forte; Robert O Ryan
Journal:  Biochem Cell Biol       Date:  2015-04-20       Impact factor: 3.626

3.  Cationic lipid nanodisks as an siRNA delivery vehicle.

Authors:  Mistuni Ghosh; Gang Ren; Jens B Simonsen; Robert O Ryan
Journal:  Biochem Cell Biol       Date:  2014-04-22       Impact factor: 3.626

4.  Use of single chain antibody derivatives for targeted drug delivery.

Authors:  Yaghoub Safdari; Vahideh Ahmadzadeh; Masoumeh Khalili; Hossein Zarei Jaliani; Vahid Zarei; Vahid Erfani-Moghadam
Journal:  Mol Med       Date:  2016-04-22       Impact factor: 6.354

Review 5.  Synthetic high-density lipoprotein-like nanoparticles as cancer therapy.

Authors:  Kaylin M McMahon; Linda Foit; Nicholas L Angeloni; Francis J Giles; Leo I Gordon; C Shad Thaxton
Journal:  Cancer Treat Res       Date:  2015

6.  Biomimetic high density lipoprotein nanoparticles for nucleic acid delivery.

Authors:  Kaylin M McMahon; R Kannan Mutharasan; Sushant Tripathy; Dorina Veliceasa; Mariana Bobeica; Dale K Shumaker; Andrea J Luthi; Brian T Helfand; Hossein Ardehali; Chad A Mirkin; Olga Volpert; C Shad Thaxton
Journal:  Nano Lett       Date:  2011-02-14       Impact factor: 11.189

7.  All-trans retinoic acid reduces cancer stem cell-like cell-mediated resistance to gefitinib in NSCLC adenocarcinoma cells.

Authors:  Wenxiu Yao; Liyang Wang; Huan Huang; Xin Li; Pinjia Wang; Kun Mi; Jia Cheng; Huifen Liu; Cuirong Gu; Lingxiao Huang; Jianming Huang
Journal:  BMC Cancer       Date:  2020-04-15       Impact factor: 4.430

8.  High-Density Lipoproteins for Therapeutic Delivery Systems.

Authors:  R Kannan Mutharasan; Linda Foit; C Shad Thaxton
Journal:  J Mater Chem B       Date:  2015-11-24       Impact factor: 6.331

Review 9.  Strategies on the nuclear-targeted delivery of genes.

Authors:  Jing Yao; Ying Fan; Yuanke Li; Leaf Huang
Journal:  J Drug Target       Date:  2013-08-22       Impact factor: 5.121

10.  Targeting Mantle Cell Lymphoma with Anti-SYK Nanoparticles.

Authors:  Ingrid Cely; Seang Yiv; Qian Yin; Anoush Shahidzadeh; Li Tang; Jianjun Cheng; Fatih M Uckun
Journal:  J Anal Oncol       Date:  2012-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.